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The chelating agents are a group of compounds with unique properties. They have the
ability to form soluble, non-ionizing stable complexes (chelates) with elements of the
alkaline earth and heavy metal series. Cations which have been so complexed can no longer
be precipitated out of solution by their usual precipitating agents. They become part of a
soluble complex anion, and are bound so securely that they no longer exhibit any character-
istic cationic properties. They have not been removed physically from solution, but have
been deionized and chemically deactivated. The chelating principle usually depends upon
the natural tendency to ring formation by compounds containing five or six atoms with
coordinate valence.
The following formulas explain the chelation reaction of disodium ethylenediamine
tetraacetic acid (ETDA)* with ionic nickel:
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The chelating principle was first recognized by Werner (1) in 1901. Morgan and Drew
(2) coined the name chelation in 1920 after the Greek work for claw (chele). As far as we can
ascertain it was first used biologically (3) in a study of the effect of free calcium ion con-
centration on the contraction of the ventricle of the frog heart. The anticoagulant action
of a chelate (calcium withdrawal) was investigated by Dyckerhoff, Marx and Ludwig (4)
in 1942. Kissin and Natelson (5) reported their application for urinary calculi in 1950.
A chelate was first used on the skin by Popovici, Geschickter and Rubin (6) in a study of
systemic absorption and its effect on blood calcium levels. Others (7, 8) have suggested
that chemical interference between the allergen and the skin might have therapeutic and
preventive application in allergic contact eczematous dermatitis. Rostenberg and Perkins
(9) demonstrated that a hound metallic ion can no longer cause allergic reaction.
The chelation phenomenon suggested an application for the inhibition of metal cutaneous
allergic sensitivity reactions. As an experimental approach to this consideration, 10 proven
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* The chelating agent used in this work was disodium ethylenadiaminetetraacetic acid
which was contributed by Dr. Albert Hemming of Geigy Pharmaceuticals as Sequestrene
Na2.
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Fin. 1. This photo demonstrates testing method. Patch test 1—2% NiSO4. Patch test
2—2% NiSO4 completely chelated with 10% ETDA. Area 3—control base over which a
patch test with 5% NiSO4 was applied. Area 4—the ETDA protective ointment over which
a 5% NiSO4 patch test was applied.
cases with strong nickel allergic sensitivity by patch test were used. These subjects were
simultaneously tested with a completely chelated identical concentration of nickel.** It
was shown that such complete chelation totally prevented the allergic contact sensitivity
reaction even though the nickel was still in solution. We have called this phenomenon
"chelation blockade".
To test the preventive efficacy of an ointment containing a chelate, the following was
done to a nickel sensitive subject: 2 patch tests of 5% nickel sulfate were applied over
uniform layers of the chelating ointment and its control base. The inhibitory action of the
chelating ointment contrasted to the base is well shown in the photograph.
** Complete chelation of a solution containing ionized nickel can be tested by adding
dimethyl glyoxine and demonstrating the failure to develop the typical strawberry-red
precipitate (the acid nickel salt of dimethyl glyoxine which would form with uncomplexed
nickel). In this work 2% NiSO4 was chelated with 10% ETDA.
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FIG. 2. 48 hours reading demonstrates the following: Test 1—3 plus allergic eczematous
contact reaction. Test 2—Negative. Test 3—3 plus allergic eczematous contact reaction.
Test 4—Plus-minus allergic reaction which disappeared in 24 hours. (There is a moderate
amount of adhesive type reaction in this case.)
A parallel experiment to the one above was done in a hair dye-sensitive patient and no
chelation deactivation was noted. We believe that this experiment indicates that a ehelate
is not a general cutaneous allergic inhibitor.
DIscussioN
These findings possibly open a new and practical approach to the therapeutic and
prophylactic management of the common metal sensitivities. The usual presence of trace
metals in toiletries, therapeutic agents and household products may be a cause for the
continuation of a dermatitis in highly sensitive patients. The addition of chelating com-
pounds to these and other commonly handled materials may eliminate this factor.
There are other possible applications of "chelation blockade" as a research tool. Those
under study are listed:
1) Protective and therapeutic medication.
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FIG. 3. 48 hours reading demonstrates the following: Patch test 1—Roux 104 (4 pIus).
Patch test 2—Roux 104 plus hydrogen peroxide (4 plus). Patch test 3—Paraphenylene
diamine (3 plus). Patch test 4—Roux 104 over ETDA ointment (3 plus). Patch test 5—
Roux 104 over control base (3 plus).
2) The inhibition of metal catalysts in cutaneous enzyme reactions (e.g. copper in
melanogenesis, etc.).
3) Elucidation of patch testing with complex materials to eliminate the role of a possible
heavy metal component as a factor in the reactions elicited.
4) Deprivation of essential trace metals to pathogenic organisms.
5) Treatment of calcifying diseases of the skin (osteoma cutis, scleroderma, etc.).
6) Removal of heavy metal deposits in the skin (beryllium, silver, mercury, etc.).
coNcLusIoNs
1) Chelation of nickel ion in solution will deactivate its antigenic ability to produce
allergic eczematous reactions of sensitivity in nickel patch test positive cases.
•:
/ Q•
4
I
I
CHELATION DEACTIVATION OF NICKEL ION 445
2) An active chelating agent applied in ointment form will inhibit the appearance of a
positive nickel patch test applied over the ointment site.
3) A chelating agent is not a general cutaneous allergic inhibitor.
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